Back to the brief

Global Business

Novartis raises core profit outlook despite a sharp fall in reported earnings

Novartis improved its annual core operating profit forecast as priority medicines supported sales. Reported quarterly profit fell sharply, however, mainly because of an impairment linked to del-desiran. The results show a substantial difference between the company’s reported and adjusted performance.

From 28 October 2026 — Global Business & Tech

28 OCT 2026 · 4/25

Novartis raised its full-year core operating profit outlook after third-quarter sales increased, despite a sharp fall in reported earnings following a drug-asset impairment.

The Swiss pharmaceutical group said net sales rose 4%, both in dollars and at constant exchange rates. Growth in medicines including Kisqali, Kesimpta and Scemblix helped offset erosion from generic competition.

Core operating income increased 10% at constant currencies, and its core operating margin reached 41.6%. Novartis now expects annual core operating income to be broadly unchanged or grow by a low-single-digit percentage, replacing an earlier forecast for a low-single-digit decline. Its sales outlook was unchanged.

Reported operating income fell 59% in dollars and net income dropped 70%, mainly because of a partial impairment of the del-desiran asset. Those declines underline the difference between statutory results and the company’s core measures.

Quarterly free cash flow was $5.1 billion, down 18% in dollars.

Global Business

Orange raises earnings growth target as overseas operations expand

Orange raised its full-year EBITDAaL growth target after quarterly revenue increased 3.6% on a comparable basis. Africa and the Middle East delivered the strongest regional growth, while France expanded more slowly. The telecoms group’s revised target concerns an adjusted operating earnings measure.

Global Business

Boeing delays 737 production target as recovery remains uneven

Boeing expects to reach its target of producing 47 Boeing 737 aircraft a month only in early 2027. The US company reported positive quarterly free cash flow, but continuing manufacturing constraints are slowing the recovery in its commercial aircraft business.

Global Business

Dangote refinery share sale draws strong demand as applications close

Dangote’s $1.6 billion refinery share offer reached its closing date amid reports of strong investor demand. Reuters reported orders worth roughly three times the target. Final allocations and any increase in the offer remained to be confirmed, ahead of a planned Nigerian listing.

Global Business

HSBC profit rises 32%, helped by the absence of last year’s legal charge

HSBC reported quarterly pre-tax profit of $9.6 billion, up 32% from a year earlier. The comparison benefited from the absence of a large legal provision. Underlying profit also increased, although the headline growth rate overstates the improvement in day-to-day performance.

Global Business

UPS raises annual outlook as revenue grows across its businesses

UPS increased its full-year revenue and adjusted profit forecasts after quarterly sales rose 6.7% to $22.9 billion. The parcel carrier expects about $92.6 billion in annual revenue and adjusted earnings of $7.28 a share, while reported quarterly earnings remained below the adjusted figure.

Global Business

Coca-Cola lifts profit forecast as sales volumes increase

Coca-Cola raised its annual comparable earnings forecast after stronger quarterly sales and a 5% increase in unit case volumes. The company now expects comparable earnings per share to grow at least 11%, with currency movements contributing to that forecast for 2026.